Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
15.57
+0.08 (0.52%)
At close: Aug 25, 2025, 4:00 PM
15.57
0.00 (0.00%)
After-hours: Aug 25, 2025, 4:00 PM EDT

Denali Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts that cover Denali Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $33.62, which forecasts a 115.93% increase in the stock price over the next year. The lowest target is $24 and the highest is $45.

Price Target: $33.62 (+115.93%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$24$33.62$32$45
Change+54.14%+115.93%+105.52%+189.02%

Analyst Ratings

The average analyst rating for Denali Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy887777
Buy777777
Hold111111
Sell000000
Strong Sell000000
Total161615151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$33$30
BuyMaintains$33$30+92.68%Aug 18, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$28$27
Strong BuyMaintains$28$27+73.41%May 19, 2025
Baird
Baird
Buy
Maintains
$30$29
BuyMaintains$30$29+86.26%May 8, 2025
Wedbush
Wedbush
Buy
Maintains
$32$30
BuyMaintains$32$30+92.68%May 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$80$32
Strong BuyMaintains$80$32+105.52%May 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
9.85M
Revenue Next Year
88.90M
from 9.85M
Increased by 802.87%
EPS This Year
-3.09
from -2.57
EPS Next Year
-3.02
from -3.09
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
335.66M48.66M108.46M330.53M-9.85M88.90M201.60M
Revenue Growth
1,158.19%-85.50%122.90%204.74%--802.87%126.78%
EPS
0.63-2.39-2.60-1.06-2.57-3.09-3.02-2.59
EPS Growth
--------
Forward PE
--------
No. Analysts
-----202016
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High78.8M271.3M480.1M
Avg9.8M88.9M201.6M
Lown/a9.4M91.5M

Revenue Growth

Revenue Growth20252026202720282029
High-
2,655.6%
440.1%
Avg-
802.9%
126.8%
Low-
-4.8%
2.9%

EPS Forecast

EPS20252026202720282029
High-2.77-2.36-1.74
Avg-3.09-3.02-2.59
Low-3.23-3.61-3.50

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.